Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters








Database
Language
Publication year range
1.
J Enzyme Inhib ; 12(2): 101-21, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9247853

ABSTRACT

This work describes a search for hexokinase inhibitors based on the interactions analysis at the active site of the X-ray resolved o-tolulyl-glucosamine-hexokinase (OTG-HK) complex structure. As the actual enzyme sequence was unknown when the X-ray structure was made (only 30% homology), the structure of the complex was rebuilt by modelling on the X-ray structure frame which allowed residues in close vicinity to the inhibitor to be defined, particularly Glu249 and Gln278. Compounds with inhibitor-bearing groups able to interact with these residues were synthesized and assayed. Some of them revealed strong affinities, in the Km range for glucose. Kinetic analysis of their behaviour towards glucose and ATP together with spectroscopic studies using NMR, allowed the determination of the corresponding inhibition patterns and provided complementary information on HK.


Subject(s)
Enzyme Inhibitors/chemical synthesis , Glucosamine/pharmacology , Hexokinase/antagonists & inhibitors , Amino Acid Sequence , Crystallography, X-Ray , Drug Design , Glucosamine/analogs & derivatives , Hydrogen Bonding , Kinetics , Magnetic Resonance Spectroscopy , Models, Chemical , Models, Molecular , Molecular Sequence Data , Protein Conformation , Saccharomyces cerevisiae , Sequence Alignment
2.
Pharmacol Ther ; 60(2): 347-65, 1993 Nov.
Article in English | MEDLINE | ID: mdl-8022865

ABSTRACT

Glycolysis in the trypanosome represents an important target for the development of new therapeutic agents due to the fact that this metabolism is essential for the parasite, glucose being its sole source of energy. In addition, different features of this metabolism and those associated with glycolytic enzymes offer opportunities for the development of efficient and selective compounds. Examples are given in this work of inhibitors directed to the enzymes aldolase and glyceraldehyde-phosphate-dehydrogenase and also of molecules acting specifically on the clusters of basic amino-acids present at the surfaces of the glycolytic enzymes in the parasite.


Subject(s)
Enzyme Inhibitors/pharmacology , Fructose-Bisphosphate Aldolase/antagonists & inhibitors , Glyceraldehyde-3-Phosphate Dehydrogenases/antagonists & inhibitors , Trypanocidal Agents/pharmacology , Trypanosoma brucei brucei/enzymology , Amino Acid Sequence , Animals , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/therapeutic use , Fructose-Bisphosphate Aldolase/chemistry , Fructose-Bisphosphate Aldolase/metabolism , Glyceraldehyde-3-Phosphate Dehydrogenases/chemistry , Glyceraldehyde-3-Phosphate Dehydrogenases/metabolism , Glycolysis/drug effects , Humans , Molecular Sequence Data , Structure-Activity Relationship , Trypanocidal Agents/chemical synthesis , Trypanocidal Agents/therapeutic use , Trypanosoma brucei brucei/drug effects , Trypanosomiasis/drug therapy , Trypanosomiasis/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL